Trial
NCT00671645
Preoperative Combined RadioChemo-Molecular Target Therapy With Capecitabine, Bevacizumab, and Radiotherapy
Phase IITERMINATEDSAFETYConfidence: HIGH
Sponsor
Austrian Breast & Colorectal Cancer Study Group
Collaborators
Hoffmann-La Roche
Condition
Rectal Cancer
Intervention
capecitabine, bevacizumab
Why stopped
reaching of step 1 (recruitment of 8 patients) per protocol -\> risk assessment -\> termination because of occurance of toxicity Grade 3 and 4
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-10-19